• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受经皮冠状动脉介入治疗的高危患者中对比剂肾病新兴预测指标的评估

Evaluation of Emerging Predictors for Contrast-Induced Nephropathy in High-Risk Patients Undergoing Percutaneous Coronary Intervention.

作者信息

Gupta Himanshu, Singh Mohit Mohan, Sahani Krishna Kumar, Gupta Ayushi, Seth Ganesh

机构信息

Cardiology, Medanta Heart Institute, Medanta Hospital, Lucknow, IND.

Cardiology, Apollomedics Super Speciality Hospital, Lucknow, IND.

出版信息

Cureus. 2024 Jul 11;16(7):e64363. doi: 10.7759/cureus.64363. eCollection 2024 Jul.

DOI:10.7759/cureus.64363
PMID:39130830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11316681/
Abstract

OBJECTIVE

The objective of this study is to investigate the occurrence and factors that influence the development of contrast-induced nephropathy (CIN) in high-risk patients undergoing angioplasty and to evaluate the effectiveness of the Mehran risk score in predicting CIN among this patient population.

MATERIALS AND METHOD

This prospective, observational study enrolled patients undergoing elective coronary angiography or a percutaneous coronary intervention (PCI) procedure. The patients were stratified into four risk groups based on the Mehran risk score, a validated tool for predicting the risk of CIN. Univariate and multivariate analyses were conducted to evaluate the risk factors associated with the development of CIN. A p-value of <0.05 was considered to indicate statistical significance.

RESULTS

During the study period, a total of 55 high-risk patients underwent PCI. The incidence of CIN was 25.5% (n=14). Univariate and multivariate analyses revealed that age >75 years and estimated glomerular filtration rate (eGFR) <60 (p<0.05) were independently associated with a significantly increased risk of developing CIN. A considerable proportion of patients (23; 41.8%) in the study were categorized as having an intermediate risk for CIN based on the Mehran risk score.

CONCLUSION

This study observed a high incidence of CIN and encourages the use of predictive tools like the Mehran risk score to assess the risk of CIN occurrence, with age over 70 years and eGFR less than 60 emerging as significant.

摘要

目的

本研究旨在调查接受血管成形术的高危患者中对比剂肾病(CIN)的发生情况及影响其发展的因素,并评估梅兰风险评分在预测该患者群体发生CIN方面的有效性。

材料与方法

这项前瞻性观察性研究纳入了接受选择性冠状动脉造影或经皮冠状动脉介入治疗(PCI)的患者。根据梅兰风险评分(一种用于预测CIN风险的有效工具),将患者分为四个风险组。进行单因素和多因素分析以评估与CIN发生相关的危险因素。p值<0.05被认为具有统计学意义。

结果

在研究期间,共有55名高危患者接受了PCI。CIN的发生率为25.5%(n = 14)。单因素和多因素分析显示,年龄>75岁和估计肾小球滤过率(eGFR)<60(p<0.05)与发生CIN的风险显著增加独立相关。根据梅兰风险评分,相当一部分患者(23例;41.8%)被归类为CIN中度风险。

结论

本研究观察到CIN的高发生率,并鼓励使用梅兰风险评分等预测工具来评估CIN发生的风险,其中年龄超过70岁和eGFR低于60被证明具有显著意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e9/11316681/26f79701664d/cureus-0016-00000064363-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e9/11316681/26f79701664d/cureus-0016-00000064363-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e9/11316681/26f79701664d/cureus-0016-00000064363-i01.jpg

相似文献

1
Evaluation of Emerging Predictors for Contrast-Induced Nephropathy in High-Risk Patients Undergoing Percutaneous Coronary Intervention.接受经皮冠状动脉介入治疗的高危患者中对比剂肾病新兴预测指标的评估
Cureus. 2024 Jul 11;16(7):e64363. doi: 10.7759/cureus.64363. eCollection 2024 Jul.
2
Predictors of contrast induced nephropathy and the applicability of the Mehran risk score in high risk patients undergoing coronary angioplasty-A study from a tertiary care center in South India.对比剂诱导的肾病的预测因素及Mehran风险评分在接受冠状动脉成形术的高危患者中的适用性——来自印度南部一家三级护理中心的研究
Indian Heart J. 2018 May-Jun;70(3):399-404. doi: 10.1016/j.ihj.2017.08.018. Epub 2017 Aug 26.
3
CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.CHA2DS2-VASC评分作为慢性完全闭塞患者经皮冠状动脉介入治疗中对比剂肾病的术前预测指标:单中心经验
BMC Cardiovasc Disord. 2019 Mar 29;19(1):74. doi: 10.1186/s12872-019-1060-0.
4
Predictors of contrast-induced nephropathy in chronic total occlusion percutaneous coronary intervention.慢性完全闭塞经皮冠状动脉介入治疗中对比剂诱导肾病的预测因素。
EuroIntervention. 2014 Feb;9(10):1173-80. doi: 10.4244/EIJV9I10A198.
5
A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes.用于预测糖尿病患者冠状动脉造影后对比剂诱导肾病的简单风险评分模型。
Clin Exp Nephrol. 2019 Jul;23(7):969-981. doi: 10.1007/s10157-019-01739-0. Epub 2019 May 2.
6
Preprocedural N-terminal pro-brain natriuretic peptide (NT-proBNP) is similar to the Mehran contrast-induced nephropathy (CIN) score in predicting CIN following elective coronary angiography.术前N末端脑钠肽前体(NT-proBNP)在预测择期冠状动脉造影术后的造影剂诱导的肾病(CIN)方面与梅兰造影剂诱导的肾病(CIN)评分相似。
J Am Heart Assoc. 2015 Apr 17;4(4):e001410. doi: 10.1161/JAHA.114.001410.
7
Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.择期行心脏导管插入术或经皮冠状动脉介入治疗的糖尿病患者对比剂肾病的预测:容量与肌酐清除率比值及碘剂量与肌酐清除率比值的作用
J Med Assoc Thai. 2010 Jan;93 Suppl 1:S29-34.
8
Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.预测行择期经皮冠状动脉介入治疗的糖尿病患者对比剂肾病:对比剂用量与估算肾小球滤过率比值的作用。
Chin Med J (Engl). 2011 Mar;124(6):892-6.
9
Contrast-Induced Nephropathy in STEMI Patients With and Without Chronic Kidney Disease.伴有和不伴有慢性肾脏病的ST段抬高型心肌梗死患者的对比剂肾病
Crit Pathw Cardiol. 2018 Mar;17(1):25-31. doi: 10.1097/HPC.0000000000000123.
10
Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.年龄、肾小球滤过率、射血分数和AGEF评分可预测接受直接经皮冠状动脉介入治疗的急性心肌梗死患者的造影剂肾病。
Catheter Cardiovasc Interv. 2013 Nov 15;82(6):878-85. doi: 10.1002/ccd.25023. Epub 2013 Jun 27.

本文引用的文献

1
Different hydration methods for the prevention of contrast-induced nephropathy in patients with elective percutaneous coronary intervention: a retrospective study.不同水化方法预防择期经皮冠状动脉介入治疗患者对比剂肾病的回顾性研究。
BMC Cardiovasc Disord. 2023 Jun 24;23(1):323. doi: 10.1186/s12872-023-03358-w.
2
Management of Angina Post Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后心绞痛的管理。
Curr Cardiol Rep. 2020 Jan 21;22(2):7. doi: 10.1007/s11886-020-1259-9.
3
A New and Simple Risk Predictor of Contrast-Induced Nephropathy in Patients Undergoing Primary Percutaneous Coronary Intervention: TIMI Risk Index.
接受直接经皮冠状动脉介入治疗患者造影剂诱发肾病的一种新型简易风险预测指标:心肌梗死溶栓治疗(TIMI)风险指数
Cardiol Res Pract. 2018 Sep 26;2018:5908215. doi: 10.1155/2018/5908215. eCollection 2018.
4
Predictors of contrast induced nephropathy and the applicability of the Mehran risk score in high risk patients undergoing coronary angioplasty-A study from a tertiary care center in South India.对比剂诱导的肾病的预测因素及Mehran风险评分在接受冠状动脉成形术的高危患者中的适用性——来自印度南部一家三级护理中心的研究
Indian Heart J. 2018 May-Jun;70(3):399-404. doi: 10.1016/j.ihj.2017.08.018. Epub 2017 Aug 26.
5
Meta-analysis of prophylactic hydration versus no hydration on contrast-induced acute kidney injury.预防性水化与不水化对造影剂诱导的急性肾损伤影响的荟萃分析。
Coron Artery Dis. 2017 Dec;28(8):649-657. doi: 10.1097/MCA.0000000000000514.
6
Risk prediction models for contrast induced nephropathy: systematic review.对比剂肾病的风险预测模型:系统评价
BMJ. 2015 Aug 27;351:h4395. doi: 10.1136/bmj.h4395.
7
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).2014年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南:欧洲心脏病学会(ESC)和欧洲心胸外科学会(EACTS)心肌血运重建特别工作组编写,欧洲经皮心血管介入协会(EAPCI)提供特别贡献。
Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278. Epub 2014 Aug 29.
8
Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.接受初次冠状动脉血管成形术患者中造影剂肾病的预测因素。
Arch Cardiovasc Dis. 2014 Aug-Sep;107(8-9):424-32. doi: 10.1016/j.acvd.2014.05.008. Epub 2014 Jul 28.
9
Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.短期瑞舒伐他汀治疗预防糖尿病和慢性肾脏病患者造影剂相关急性肾损伤。
J Am Coll Cardiol. 2014;63(1):62-70. doi: 10.1016/j.jacc.2013.09.017. Epub 2013 Sep 26.
10
Prevention of Contrast-Induced Nephropathy (CIN) in Interventional Radiology Practice.介入放射学实践中对比剂诱导的肾病(CIN)的预防
Semin Intervent Radiol. 2010 Dec;27(4):348-59. doi: 10.1055/s-0030-1267860.